General Western Blot Reagents
Abcam Ghrelin (human), Endogenous GHS agonist, 1MG
MW 3370.91 g/mol, Purity >95%. Endogenous agonist peptide for the ghrelin (GHS) receptor. Stimulates release of growth hormone from the pituitary gland and regulates feeding, appetite, growth and energy homeostasis.
The product is subject to the following: Abcam Restricted Use Statement
Abcam tBuBHQ (BHQ), Sarco-endoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor, 100MG
MW 222.32 Da, Purity >99%. Sarco-endoplasmic reticulum Ca2+ ATPase (SERCA) inhibitor. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Pyocyanin, Catalase inhibitor, 25MG
MW 210.23 Da, Purity >98%. Catalase inhibitor. Aryl hydrocarbon receptor activator (Ki = 5.4 μM). Reduces gene expression of catalase. Promotes extracellular DNA release. Generates ROS. Induces apoptosis in neutrophils in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam Galanin (porcine), Endogenous galanin receptor agonist, 1MG
MW 3210.5 Da. Galanin (porcine), Endogenous galanin receptor agonist. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SBD-F (7-Fluorobenzofurazan-4-sulfonic acid ammonium salt), Fluorescent thiol indicator, 25MG
MW 235.2 Da, Purity >98%. Fluorescent thiol indicator. Reacts with sulfhydryl groups to produce highly fluorescent compounds. Attains low detection limits.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Clopamide, Na+/2Cl- cotransporter inhibitor. Diuretic., 500MG
MW 345.8 Da, Purity >98%. Selective Na+/2Cl- cotransporter inhibitor. Diuretic activity *in vivo*. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam 4-(Trifluoromethyl)umbelliferyl phosphate, Fluorogenic alkaline phosphatase substrate.
4-(Trifluoromethyl)umbelliferyl phosphate, Fluorogenic alkaline phosphatase substrate.
The product is subject to the following: Abcam Restricted Use Statement
Abcam N-(3-O x ododecanoyl)-L-homoserine lactone, involved in quorum sensing, 10MG
MW 297.39 g/mol, Purity >98%. Autoinducer involved in quorum sensing by Pseudomonas aeruginosa. Member of N-acyl-homoserine lactone (AHL) family that regulate gene expression in gram-negative bacteria and are involved in the processes of bacterial quorum sensing.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Quinol 1h, Antitumor agent, 5MG
MW 365.4 Da, Purity >99%. Potent, selective antitumor agent. Antitumor activity observed in HCT 116 (GI₅₀ = 40 nM) and HT 29 (GI₅₀ = 380 nM), and in breast cancer cell lines. Potent inhibitory effect in NCI 60 cells (GI₅₀ =16 nM and LC₅₀ = 2.24 μM). Active in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Acetyl-L-alanyl-L-glutamine, Polypeptide, 5G
MW 259.26 Da, Purity >98%. Polypeptide for proteomics research. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
![Abcam 7-Diethylamino-3-[N-(4-maleimidoethyl)carbamoyl]coumarin, Thiol-reactive fluorescent probe, 20MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502705259.JPG-250.jpg)
Abcam 7-Diethylamino-3-[N-(4-maleimidoethyl)carbamoyl]coumarin, Thiol-reactive fluorescent probe, 20MG
MW 383.4 g/mol, Purity >97%. Thiol-reactive fluorescent probe for protein labeling. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam VAS 2870, NADPH o x idase inhibitor, 50MG
MW 360.4 g/mol, Purity >98%. NADPH oxidase inhibitor. Blocks PDGF-mediated NADPH activation and ROS production. Inhibits PMS-induced oxidative burst (IC₅₀ = 2 μM, HeLa cells). Shows anti-ischemic effects ex vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam 5-CFDA N-succinimidyl ester, Fluorogenic esterase substrate.
5-CFDA N-succinimidyl ester, Fluorogenic esterase substrate.
The product is subject to the following: Abcam Restricted Use Statement
Abcam (plusminus)-1,2-Dioleoylglycerol (18:1), Protein kinase C activator.
(plusminus)-1,2-Dioleoylglycerol (18:1), Protein kinase C activator.
The product is subject to the following: Abcam Restricted Use Statement
Abcam (R)-Butaprost, EP2 agonist, 5MG
MW 408.6 Da, Purity >98%. Selective EP2 agonist. PGE2 structural analog. Inhibits chemotaxis (EC50 = 106 nM, maximal effect of PGE2). Increases neutrophil cyclic AMP levels.
The product is subject to the following: Abcam Restricted Use Statement